1Mckeith IG,Galako D,Kosaka K,et al.Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies:report of the consortium on DLB international workshop.Neurology,1996,47:1113
2Gomez TE,Newell K,Irizarry MC,et al.Clinical and quantitative pathologic correlates of dementia with Lewy bodies.Neurology,1999,53:1284
3Goedert M,Jakes R,Spillantini MG.α-synuclein in Lewy body.Neurosci News,1997,1:47
4Lippa CF,Ozawa K,Mann DMA,et al.Deposition of β-amyloid subtypes 40 and 42 differentiates dementia with Lewy bodies from Alzheimer disease.Arch Neurol,1999,56:1111
5Schneider JA,Gearing M,Robbins RS,et al.Apolipoprotein E genotype in diverse neurodegenerative disorder.Ann Neurol,1995,38:131
6Saitoh T,Xia Y,Chen X,et al.The CYP2D6B mutant allele is over represented in the Lewy body variant of Alzheimer's disease.Ann Neurol,1995,37:110
7Mckeith I,O'Brien J.Dementia with Lewy bodies.Aust N Z J Psychiatry,1999,33:800
8Barber R,Panikkar A,Mckeith IG.Dementia with Lewy bodies:diagnosis and management.Int J Geriatr Psychiatry,2001,16(suppl 1):S12-18
9Wilcock GK,Bucks RS,Kenneth Rockwood.Diagnosis and management of dementia:a manual for memory disorders teams.New York:Oxford University Press Inc,1999:241-245
10Mori E.Dementia with Lewy bodies.Nippon Ronn Igakkai Zasshi,2000,37:772
8[3]Klein WL,Krafft GA,Finch CE.Targeting small Abeta oligomers:the solution to an Alzheimer's disease conundrum[J]?Trends Neurosci,2001,24:219-224.
9[7]Knopman DS,De Kosky ST,Cummings JL,et al.Practice parameter:Diagnosis of dementia (an evidence-based review)Report of the Quality Standards Subcommittee of the American Academy of Neurology[J].Neurology,2001,56:1143-1153.
10[10]Ghanbari H,Ghanbari K,Munzar M,et al.Biochemical assay for AD7C-NTP in urine as an Alzheimer's disease marker[J].J Clin LabAnal,1998,12:285-288.
